antiviral

Ebola
Biotech

US taps small biotech for experimental Ebola treatment

Mapp Biopharmaceutical has shipped doses of an experimental Ebola antibody treatment for potential use in people at high risk.
Brett Giroir

Sanofi backs Altesa's $75M series B to bankroll rhinovirus study

Feb 19, 2026 7:00am
merck

Merck pays $9.2B for owner of flu antiviral J&J rejected

Nov 14, 2025 8:25am
Glowing puzzle piece fitting into puzzle

Gilead pumps up virology pipeline with drug transporter deal

Sep 29, 2025 10:35am
RSV

Enanta sees RSV drug fail phase 2b but finds positives

Sep 29, 2025 8:05am
arrow back backwards u-turn turn around reverse

Ascletis slashes funds for former core programs in obesity pivot

Mar 26, 2025 10:00am